Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Nocardia rubra cell wall skeleton for radiation-induced skin injury (Phase I/II)
CTR20250790Phase 2Active
- Sponsor
- Liaoning Tian'an Biological Pharmaceutical
- Start
- Mar 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nocardia rubra cell wall skeleton in radiodermatitis, sponsored by Liaoning Tian'an Biological Pharmaceutical. Started Mar 2025; status: active.
02
Drugs
nocardia rubra cell wall skeleton
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on CTR20250790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250790.